Ventfort A-3
Quick summary
A capsule bioregulator product aimed at blood-vessel tissue. Research focus: peptide bioregulators and vascular tissue. SRP's starting dose for this compound is still pending.
Overview
A capsule bioregulator product aimed at blood-vessel tissue.
Looking for research material? Simple Research Peptides lists Ventfort A-3 Blood Vessel Peptide Bioregulator – 60 Capsules for laboratory research use.
Mechanism
Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression. Most of the evidence comes from cell and animal studies by a small number of research groups.
Research areas
- peptide bioregulators
- vascular tissue
Storage & reconstitution
Supplied in capsule form. Store sealed in a cool, dry place away from light and moisture.
Recommended starting dose (low and slow)
| Starting dose | Pending - to be added by SRP |
|---|---|
| Frequency | Pending - to be added by SRP |
| Reconstitution | Pending - to be added by SRP |
Route and timing
Route: Oral.
Timing: Pending - to be added by SRP
Cycle length and repeat
Pending - to be added by SRP
Half-life
Approximate, for Bobby's review: Not well characterized in published research.
Side effects
Pending - to be added by SRP
Suggested bloodwork and monitoring
Draft, for Bobby's review: CBC and comprehensive metabolic panel (kidney and liver function, electrolytes) before starting and again after a few weeks.
Cautions
Pending - to be added by SRP
Reconstitution calculator
Math aid only. It converts the numbers you enter; it is not dosing advice. For research use only.
Frequently asked questions
What is Ventfort A-3 studied for?
In research it is studied for peptide bioregulators and vascular tissue. Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression.
How is Ventfort A-3 given in research?
Oral. SRP has not yet published a frequency for this compound.
What amount should a researcher start with?
SRP has not yet published a starting dose for Ventfort A-3. Contact SRP before starting any research protocol, and do not guess.
Related peptides
Last updated: October 19, 2026